Stocks: Overview  

Tuesday, June 18, 2013 2:45:29 AM EDT
Show Me
|

 

Cytori Therapeutics IncCYTX
VF CorpVFC
TCW High-Yield Bond Fund Class NTGHNX
Wells Fargo & CoWFC
Apple IncAAPL
Scotts Miracle-Gro CoSMG
Fiat SpAFIATY
Chesapeake Energy CorpCHK
Paychex IncPAYX
Cognizant Technology Solutions CorpCTSH

Cytori Therapeutics IncNASDAQ:CYTX    

Health Care : BiotechnologySmall Cap Growth
$2.32 
 
 0.00 (0.00%)        
Bid
--
Ask
--
B/A Size
--
High
2.33
Low
2.27
Volume
177,726 (Below Avg)
Change company  Symbol lookup
As of June 17, 2013 4:00pm ET
  • Summary
  • News
  • Charts
  • Earnings
  • Fundamentals
  • Valuation
  • Calendar
  • Analyst Reports
  • SEC Filings

2.32

155.8M


2.28

67.2M


2.27 - 2.33

-0.50


190.6K

--


4:00p ET 06/17/13

No Regular Dividends


5.3K

--


Low
High

1.9


4.98%

20.49


69.4%

11.71


65.0%

Historical Quotes & Splits
 

Current|1mo|3mo|6mo|1yr
DJIA
S&P 500
NASDAQ
SMA(50)
View Advanced Chart
  • News
  • Industry Position
  • Company Profile

May 29, 2013

1:18p
FDA-Approved Clinical Trial to Test Effectiveness of Fat-Derived Regenerative Cells on Heart Failure Patients   (Business Wire)

May 13, 2013

8:40a
Medivation Loss Narrower Than Expected - Analyst Blog   (Zacks.com)

May 9, 2013

4:01p
Cytori Reports First Quarter 2013 Business and Financial Results   (Business Wire)

May 8, 2013

5:35p
Osiris Loss In-Line with Expectations - Analyst Blog   (Zacks.com)

May 2, 2013

8:00a
Cytori to Webcast First Quarter Financial Results on May 9   (Business Wire)
Go to All Current & Historical News
Events
05/09/2013
Q1 2013 Cytori Therapeutics Inc Earnings Release - Actual: $-0.11
03/07/2013
Q4 2012 Cytori Therapeutics Inc Earnings Release - Actual: $-0.06
11/08/2012
Q3 2012 Cytori Therapeutics Inc Earnings Release - Actual: $-0.19
08/08/2012
Q2 2012 Cytori Therapeutics Inc Earnings Release - Actual: $-0.13
More Calendar Events
Market data accompanied by       is delayed by at least 15 minutes for NASDAQ, AMEX, NYSE and Options. Duration of the delay for other exchanges vary.
THOMSON REUTERS  
Market data and information provided by Thomson Reuters; ©  
Thomson Reuters Limited.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Information and news provided by 
, 
Computrade Systems, Inc., 
 , 
,  
, 
and 

Copyright ©2013. All rights reserved.


S&P Capital IQ Research Disclosure /public-2:45:28

3rd Party Research Disclosure /public-2:45:28

Market Data Disclosure